Trial Profile
A long term study investigating the effect of raltegravir base therapy in patients with HIV-1-infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2015
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 06 Dec 2015 New trial record